金陵药业(000919.SZ)：福州梅峰制药厂的水解蛋白注射液获得药品再注册批准通知书

Core Viewpoint - Jinling Pharmaceutical (000919.SZ) has received a drug re-registration approval notice for hydrolyzed protein injection from the Fujian Provincial Drug Administration, indicating a significant regulatory milestone for the company [1] Group 1: Company Developments - Jinling Pharmaceutical's subsidiary, Fuzhou Meifeng Pharmaceutical Factory, has been granted approval for hydrolyzed protein injection, which is a sterilized solution of hydrolyzed casein and whey protein with sorbitol [1] - The hydrolyzed protein injection is primarily used for severe amino acid deficiency caused by major surgical trauma, extensive burns, and various diseases leading to hypoproteinemia [1]